Low Sugar Metabolite Associated With Disability and Neurodegeneration in Multiple Sclerosis – Neuroscience News
Lower serum levels of the sugar metabolite GlcNAc was associated with progressive disability and neurodegeneration in patients with multiple sclerosis.